Directory
>
Lovisa Afzelius
Lovisa Afzelius
General Partner | A+ Science
Belmont, Massachusetts, United States
Lovisa Afzelius
Summary
Lovisa Afzelius is a seasoned leader in the biotechnology and pharmaceutical industries, currently serving as a General Partner at Flagship Pioneering. With over 20 years of experience, she has held pivotal roles such as CEO and board member in various innovative biotech startups and major pharmaceutical companies. Lovisa's academic foundation in Computational Chemistry, combined with her executive MBA from MIT, empowers her to drive data-driven drug discovery and development strategies. She has a proven track record of leading cross-functional teams and managing complex global projects across diverse therapeutic areas. Recognized as one of the most influential persons under 40 in Sweden, Lovisa is passionate about transforming human health through cutting-edge scientific ventures. Her leadership style is characterized by ambition, strategic thinking, and a commitment to fostering innovation in life sciences. Outside of her professional pursuits, she actively contributes to the Swedish American Chamber of Commerce, promoting collaboration and business opportunities.
Lovisa Afzelius
Work Experience
General Partner at
Flagship Pioneering
September 2023 - Present
Co-founder & CEO at
Prologue Medicines
October 2022 - Present
Board Member | Co-founder at
A+ Science
February 2022 - Present
Co-founder & CEO at
Metaphore Biotechnologies, Inc.
May 2021 - Present
Co-founder & CEO at
Apriori Bio
October 2020 - Present
Founding CEO & Director at
Alltrna
March 2020 - Present
Board Of Directors at
SACC-NE (The Swedish-American Chamber of Commerce New England)
November 2017 - Present
Origination Partner at
Flagship Pioneering
February 2020 - July 2024
Chairman Of The Board | Co-Founder at
A+ Science
December 2017 - February 2022
President at
Generate:Biomedicines
February 2020 - February 2021
Senior Vice President at
Repertoire Immune Medicines
September 2017 - February 2020
Executive Director, Head of Systems Immunology at
Pfizer, Inc.
February 2017 - September 2017
Head of Computational Precision Medicine, Senior Director, Inflammation & Immunology RU at
Pfizer, Inc.
April 2015 - February 2017
Senior Director , Immunoscience RU at
Pfizer, Inc.
May 2013 - April 2015
CEO at
Biochromix Pharma
December 2012 - May 2013
Project Director at Neuroscience Innovative Medicine Unit at
Astrazeneca R And D
November 2010 - October 2012
Global in vitro drug metabolism and pharmacokinetic (DMPK) leader at
Astrazeneca R And D
October 2009 - December 2010
Candidate Drug Delivery Leader, CNS&Pain at
Astrazeneca R And D
May 2009 - November 2010
Associate Director DMPK, CNS&Pain at
Astrazeneca R And D
April 2007 - August 2008
Associate Principal Scientist, CVGI at
Astrazeneca R And D
January 2004 - May 2007
Industrial PhD student in collaboration with Uppsala University at
Astrazeneca R And D
June 2001 - March 2004
Lovisa Afzelius
Education
Massachusetts Institute of Technology - Sloan School of Management, Executive Mba
January 2014 - January 2016
University of Uppsala (PhD), Doctoral
January 2001 - January 2004
University of Gothenburg (MSc)
January 1995 - January 2000
Frequently Asked Questions about Lovisa Afzelius
What is Lovisa Afzelius email address?
Lovisa Afzelius's primary email address is ***************@sacc-ne.org. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Lovisa Afzelius work for?
Lovisa Afzelius is a General Partner at A+ Science, a company specializing in Scientific Research & Development Services.
Where Lovisa Afzelius graduated from?
Lovisa Afzelius holds a degree in Master Of Business Administration from Massachusetts Institute of Technology - Sloan School of Management.
How can I directly contact Lovisa Afzelius?
To contact Lovisa Afzelius directly, you can use the email address ***************@sacc-ne.org. Complete contact information is available upon registration with Muraena.
Is Lovisa Afzelius an immigrant?
Yes, Lovisa Afzelius is an immigrant and currently based in United States
Who is Lovisa Afzelius?
Lovisa Afzelius is a seasoned leader in the biotechnology and pharmaceutical industries, currently serving as a General Partner at Flagship Pioneering. With over 20 years of experience, she has held pivotal roles such as CEO and board member in various innovative biotech startups and major pharmaceutical companies. Lovisa's academic foundation in Computational Chemistry, combined with her executive MBA from MIT, empowers her to drive data-driven drug discovery and development strategies. She has a proven track record of leading cross-functional teams and managing complex global projects across diverse therapeutic areas. Recognized as one of the most influential persons under 40 in Sweden, Lovisa is passionate about transforming human health through cutting-edge scientific ventures. Her leadership style is characterized by ambition, strategic thinking, and a commitment to fostering innovation in life sciences. Outside of her professional pursuits, she actively contributes to the Swedish American Chamber of Commerce, promoting collaboration and business opportunities.
Lovisa`s contact details
***************@sacc-ne.org
***************@elsa.science
***************@astrazeneca.com
*********@flagshippioneering.com
******@pfizer.com